293 related articles for article (PubMed ID: 17365221)
21. An alternative approach to assess exchangeability of a test treatment and the standard treatment with normally distributed response.
Tsong Y; Shen M
J Biopharm Stat; 2007; 17(2):329-38. PubMed ID: 17365227
[TBL] [Abstract][Full Text] [Related]
22. Issues of simultaneous tests for noninferiority and superiority.
Ng TH
J Biopharm Stat; 2003 Nov; 13(4):629-39; discussion 641-62. PubMed ID: 14584713
[TBL] [Abstract][Full Text] [Related]
23. Placebo or active control trials of antipsychotic drugs?
Fleischhacker WW; Czobor P; Hummer M; Kemmler G; Kohnen R; Volavka J
Arch Gen Psychiatry; 2003 May; 60(5):458-64. PubMed ID: 12742866
[TBL] [Abstract][Full Text] [Related]
24. Multiple testing of noninferiority hypotheses in active controlled trials.
Hung HM; Wang SJ
J Biopharm Stat; 2004 May; 14(2):327-35. PubMed ID: 15206530
[TBL] [Abstract][Full Text] [Related]
25. A bootstrap-based test for establishing noninferiority in clinical trials.
Chen M; Kianifard F; Dhar SK
J Biopharm Stat; 2006 May; 16(3):357-63. PubMed ID: 16724490
[TBL] [Abstract][Full Text] [Related]
26. A unifying approach to non-inferiority, equivalence and superiority tests via multiple decision processes.
Hirotsu C
Pharm Stat; 2007; 6(3):193-203. PubMed ID: 17879327
[TBL] [Abstract][Full Text] [Related]
27. Modified Haybittle-Peto group sequential designs for testing superiority and non-inferiority hypotheses in clinical trials.
Lai TL; Shih MC; Zhu G
Stat Med; 2006 Apr; 25(7):1149-67. PubMed ID: 16189814
[TBL] [Abstract][Full Text] [Related]
28. TACT method for non-inferiority testing in active controlled trials.
Wang SJ; Hung HM
Stat Med; 2003 Jan; 22(2):227-38. PubMed ID: 12520559
[TBL] [Abstract][Full Text] [Related]
29. A covariate-adjustment regression model approach to noninferiority margin definition.
Nie L; Soon G
Stat Med; 2010 May; 29(10):1107-13. PubMed ID: 20209669
[TBL] [Abstract][Full Text] [Related]
30. Avoiding ambiguity with the Type I error rate in noninferiority trials.
Kang SH
J Biopharm Stat; 2016; 26(3):452-65. PubMed ID: 26252624
[TBL] [Abstract][Full Text] [Related]
31. Strength of evidence of non-inferiority trials-The adjustment of the type I error rate in non-inferiority trials with the synthesis method.
Kang SH; Tsong Y
Stat Med; 2010 Jun; 29(14):1477-87. PubMed ID: 20535762
[TBL] [Abstract][Full Text] [Related]
32. Design and analysis of non-inferiority mortality trials in oncology.
Rothmann M; Li N; Chen G; Chi GY; Temple R; Tsou HH
Stat Med; 2003 Jan; 22(2):239-64. PubMed ID: 12520560
[TBL] [Abstract][Full Text] [Related]
33. The issue of multiplicity in noninferiority studies.
Ke C; Ding B; Jiang Q; Snapinn SM
Clin Trials; 2012 Dec; 9(6):730-5. PubMed ID: 22879575
[TBL] [Abstract][Full Text] [Related]
34. Testing non-inferiority and superiority for two endpoints for several treatments with a control.
Lawrence J
Pharm Stat; 2011; 10(4):318-24. PubMed ID: 20949636
[TBL] [Abstract][Full Text] [Related]
35. Monitoring rare serious adverse events from a new treatment and testing for a difference from historical controls.
Fay MP; Huang CY; Twum-Danso NA
Clin Trials; 2007; 4(6):598-610. PubMed ID: 18042569
[TBL] [Abstract][Full Text] [Related]
36. A note on partial covariate-adjustment and design considerations in noninferiority trials when patient-level data are not available.
Nie L; Soon GG; Qi K; Chen Y; Chu H
J Biopharm Stat; 2013; 23(5):1042-53. PubMed ID: 23957514
[TBL] [Abstract][Full Text] [Related]
37. Approaches for testing noninferiority in two-arm trials for risk ratio and odds ratio.
Chowdhury S; Tiwari RC; Ghosh S
J Biopharm Stat; 2019; 29(3):425-445. PubMed ID: 30744476
[TBL] [Abstract][Full Text] [Related]
38. How to deal with multiple treatment or dose groups in randomized clinical trials?
Hothorn LA
Fundam Clin Pharmacol; 2007 Apr; 21(2):137-54. PubMed ID: 17391286
[TBL] [Abstract][Full Text] [Related]
39. Bayesian approach to noninferiority trials for proportions.
Gamalo MA; Wu R; Tiwari RC
J Biopharm Stat; 2011 Sep; 21(5):902-19. PubMed ID: 21830922
[TBL] [Abstract][Full Text] [Related]
40. Choosing the analysis population in non-inferiority studies: per protocol or intent-to-treat.
Matilde Sanchez M; Chen X
Stat Med; 2006 Apr; 25(7):1169-81. PubMed ID: 16397861
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
